Skip to main content

Expert opinion

Activity tracking watch

14-10-2020 | Devices and technology | Editorial | Article

Use of wearable activity trackers to detect disease flares in rheumatic diseases

Antsa Rakotozafiarison and Laure Gossec explore how wearable activity trackers coupled with machine learning can be used to monitor flares in people with rheumatic diseases.

Children running (symbolic image with models)

24-03-2020 | Physical activity | Editorial | Article

Exercise recommendations for children with juvenile idiopathic arthritis

Sangeeta Sule discusses the current recommendations for physical activity in children with juvenile idiopathic arthritis.

Microbiome

07-02-2020 | Spondyloarthropathies | Editorial | Article

The microbiome in spondyloarthritis and its relationship with the IL-23/IL-17 axis

Tejpal Gill discusses the relationship between the microbiome and the IL-23/IL-17 axis in spondyloarthritis.

Antibodies

15-01-2020 | Myositis | Editorial | Article

Do myositis-specific antibodies have an impact on the treatment of idiopathic inflammatory myopathies?

Latika Gupta and Rohit Aggarwal evaluate the use of myositis-specific antibodies in the classification and management of this disease.

Machine learning

06-01-2020 | Artificial intelligence | Editorial | Article

The use of machine learning to optimize treatment of rheumatic diseases

Martin Krusche and Gerd Burmester discuss the potential for machine learning in the treatment of rheumatic diseases, including identification of clinical subgroups and prediction of response to therapy.

Figure 2

04-12-2019 | Calcium pyrophosphate deposition disease | Editorial | Article

Calcium pyrophosphate deposition disease: A common, under-diagnosed condition

Abhishek Abhishek outlines the pathogenesis, diagnosis, and clinical presentations of calcium pyrophosphate deposition disease.

Deep learning

27-11-2019 | Diagnosis and screening | Editorial | Article

Application of machine learning in predicting early diagnosis of rheumatic diseases

Nathan Foulquier and Alain Saraux evaluate the use of machine learning for the classification and diagnosis of rheumatic diseases.

Spine

11-10-2019 | Axial spondyloarthritis | Editorial | Article

Do current therapies slow radiographic progression in axial spondyloarthritis/ ankylosing spondylitis?

Preston Le, Stephanie Qi, and Liron Caplan discuss the efficacy of current therapies in slowing radiographic progression of ankylosing spondylitis.

Uric acid test

10-09-2019 | Gout | Editorial | Article

The 2018 updated EULAR recommendations for the diagnosis of gout: What's new, what's changed, and what's gone?

Editorial Board member Fernando Pérez-Ruiz summarizes the key changes in the 2018 updated EULAR recommendations for the diagnosis of gout.

Human brain digital illustration

13-08-2019 | Systemic lupus erythematosus | Editorial | Article

Neuropsychiatric systemic lupus erythematosus: Issues in diagnosis and management

Antigone Pieta, Dionysis Nikolopoulos, and Antonis Fanouriakis discuss the causes and management of neuropsychiatric systemic lupus erythematosus, and outline unmet needs in the diagnosis and treatment of this disease.

Syringe and white pills on blue background

10-07-2019 | Psoriatic arthritis | Highlight | Article

Methotrexate versus etanercept as first-line therapy for psoriatic arthritis

William Tillett, Deepak Jadon, and Jobie Evans debate the clinical reasons relating to the efficacy, safety, and practicality of using etanercept or methotrexate as first-line therapy for psoriatic arthritis.

Tablets

20-06-2019 | Systemic lupus erythematosus | Highlight | Article

Systemic lupus erythematosus: Novel therapies and targeted treatments

Andrea Fava and George Stojan review new strategies and agents for the treatment of systemic lupus erythematosus that have most recently showed promise in clinical trials.

DNA and chromosomes (illustration)

12-04-2019 | Gout | Editorial | Article

Using genetic studies to assess the impact of hyperuricemia in cardiometabolic and chronic kidney disease

Editorial Board member Fernando Pérez-Ruiz discusses the impact of hyperuricemia in cardiometabolic and chronic kidney disease, focusing on the role of genetic studies in showing a causal association between these conditions.

Jaw

27-03-2019 | Juvenile idiopathic arthritis | Editorial | Article

Temporomandibular joint involvement in juvenile idiopathic arthritis: Diagnosis and management

The authors provide an overview of temporomandibular joint involvement in children with juvenile idiopathic arthritis, including imaging methods for diagnosis, clinical examination recommendations, and treatment options.

Figure 2

18-03-2019 | Juvenile idiopathic arthritis | Editorial | Article

Enhancing clinical assessment with ultrasonography in juvenile idiopathic arthritis

Johannes Roth outlines the rationale behind the use of musculoskeletal ultrasonography in children with juvenile idiopathic arthritis, including enhancement of clinical assessment as part of a treat-to-target approach.

Intestinal villi- microbiome

01-03-2019 | Juvenile idiopathic arthritis | Editorial | Article

The microbiota in juvenile idiopathic arthritis: What’s wrong, and what can we do?

In this editorial, Matthew Stoll explores the role of the microbiota in the pathogenesis of juvenile idiopathic arthritis, as well as current research into therapeutic alterations of the microbiome.

Osteoporosis (illustration)

18-02-2019 | Osteoporosis | Editorial | Article

Osteoporosis therapy: Drug holiday or not?

Malachi McKenna explains the risks of long-term bisphosphonate therapy in patients with osteoporosis, and the rationale for a drug holiday. He also compares bisphosphonates with denosumab, and explains why denosumab should not be followed by a drug holiday.

Cardiovascular disease (illustration)

12-02-2019 | Cardiovascular disease | Editorial | Article

Cardiovascular risk management in arthritis: Why still a bridge too far?

Cardiovascular disease is the main cause of death in patients with rheumatoid arthritis. In this editorial Michael Nurmohamed discusses the EULAR recommendations for cardiovascular risk management, focusing on the role of the rheumatologist.

Antibodies (illustration)

11-02-2019 | Rheumatoid arthritis | Editorial | Article

20 years of TNF inhibitors in rheumatoid arthritis

Understanding and treatment of rheumatoid arthritis has changed dramatically over the past two decades. Peter Taylor describes the impact of biologic tumor necrosis factor inhibitors on the management of this disease.

Kidneys

29-01-2019 | Lupus nephritis | Editorial | Article

Emerging therapies for lupus nephritis

Lupus nephritis is the most common organ-threatening complication of systemic lupus erythematosus, and current treatment regimens are only partially effective and are potentially toxic. In this editorial, the authors focus on emerging therapeutics to treat this disease.